236 related articles for article (PubMed ID: 20559089)
21. Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas.
Lee CC; Kano H; Yang HC; Xu Z; Yen CP; Chung WY; Pan DH; Lunsford LD; Sheehan JP
J Neurosurg; 2014 Mar; 120(3):647-54. PubMed ID: 24405068
[TBL] [Abstract][Full Text] [Related]
22. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery.
Leavitt JA; Stafford SL; Link MJ; Pollock BE
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):524-7. PubMed ID: 24074926
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas.
Park KJ; Kano H; Parry PV; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
Neurosurgery; 2011 Dec; 69(6):1188-99. PubMed ID: 21552167
[TBL] [Abstract][Full Text] [Related]
24. Dose-volume analysis of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery.
Pollock BE; Link MJ; Leavitt JA; Stafford SL
Neurosurgery; 2014 Oct; 75(4):456-60; discussion 460. PubMed ID: 24902082
[TBL] [Abstract][Full Text] [Related]
25. Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response.
Minniti G; Scaringi C; Poggi M; Jaffrain Rea ML; Trillò G; Esposito V; Bozzao A; Enrici MM; Toscano V; Enrici RM
Eur J Endocrinol; 2015 Apr; 172(4):433-41. PubMed ID: 25627653
[TBL] [Abstract][Full Text] [Related]
26. Effects of Neuroanatomic Structural Distances on Pituitary Function After Stereotactic Radiosurgery: A Multicenter Study.
Ironside N; Chen CJ; Xu Z; Schlesinger D; Lee Vance M; Hong GK; Jane JA; Patel S; Bindal SK; Niranjan A; Lunsford LD; Liscak R; Chytka T; Jezkova J; Saifi O; Trifiletti DM; Berger A; Alzate J; Bernstein K; Kondziolka D; Speckter H; Hernandez W; Lazo E; Peker S; Samanci Y; Zacharia BE; Mau C; Wegner RE; Shepard MJ; Mathieu D; Maillet M; Sheehan JP
Neurosurgery; 2023 May; 92(5):1035-1042. PubMed ID: 36700741
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of proton therapy for patients with functional pituitary adenomas.
Wattson DA; Tanguturi SK; Spiegel DY; Niemierko A; Biller BM; Nachtigall LB; Bussière MR; Swearingen B; Chapman PH; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):532-9. PubMed ID: 25194666
[TBL] [Abstract][Full Text] [Related]
28. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[TBL] [Abstract][Full Text] [Related]
29. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission.
Pollock BE; Jacob JT; Brown PD; Nippoldt TB
J Neurosurg; 2007 May; 106(5):833-8. PubMed ID: 17542527
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic radiosurgery of pituitary adenomas.
Liščák R; Ježková J; Marek J
Neurosurg Clin N Am; 2013 Oct; 24(4):509-19. PubMed ID: 24093569
[TBL] [Abstract][Full Text] [Related]
31. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study.
Attanasio R; Epaminonda P; Motti E; Giugni E; Ventrella L; Cozzi R; Farabola M; Loli P; Beck-Peccoz P; Arosio M
J Clin Endocrinol Metab; 2003 Jul; 88(7):3105-12. PubMed ID: 12843150
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium.
Sheehan JP; Niranjan A; Sheehan JM; Jane JA; Laws ER; Kondziolka D; Flickinger J; Landolt AM; Loeffler JS; Lunsford LD
J Neurosurg; 2005 Apr; 102(4):678-91. PubMed ID: 15871511
[TBL] [Abstract][Full Text] [Related]
33. Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas.
Tanaka S; Link MJ; Brown PD; Stafford SL; Young WF; Pollock BE
World Neurosurg; 2010 Jul; 74(1):147-52. PubMed ID: 21300006
[TBL] [Abstract][Full Text] [Related]
34. Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study.
Voges J; Kocher M; Runge M; Poggenborg J; Lehrke R; Lenartz D; Maarouf M; Gouni-Berthold I; Krone W; Muller RP; Sturm V
Cancer; 2006 Sep; 107(6):1355-64. PubMed ID: 16894526
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic radiosurgery as an alternative to fractionated radiotherapy for patients with recurrent or residual nonfunctioning pituitary adenomas.
Pollock BE; Carpenter PC
Neurosurgery; 2003 Nov; 53(5):1086-91; discussion 1091-4. PubMed ID: 14580275
[TBL] [Abstract][Full Text] [Related]
36. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas.
Mitsumori M; Shrieve DC; Alexander E; Kaiser UB; Richardson GE; Black PM; Loeffler JS
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):573-80. PubMed ID: 9806517
[TBL] [Abstract][Full Text] [Related]
37. Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas.
Vladyka V; Liscák R; Novotný J; Marek J; Jezková J
Neurosurgery; 2003 Feb; 52(2):309-16; discussion 316-7. PubMed ID: 12535358
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic Radiosurgery as the Initial Treatment for Patients with Nonfunctioning Pituitary Adenomas.
Hasegawa T; Shintai K; Kato T; Iizuka H
World Neurosurg; 2015 Jun; 83(6):1173-9. PubMed ID: 25700971
[TBL] [Abstract][Full Text] [Related]
39. Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife?
Marek J; Jezková J; Hána V; Krsek M; Bandúrová L; Pecen L; Vladyka V; Liscák R
Eur J Endocrinol; 2011 Feb; 164(2):169-78. PubMed ID: 21071488
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study.
Cohen-Inbar O; Xu Z; Lee CC; Wu CC; Chytka T; Silva D; Sharma M; Radwan H; Grills IS; Nguyen B; Siddiqui Z; Mathieu D; Iorio-Morin C; Wolf A; Cifarelli CP; Cifarelli DT; Lunsford LD; Kondziolka D; Sheehan JP
J Neurooncol; 2017 Oct; 135(1):67-74. PubMed ID: 28913674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
